In this context, we speculate that a gradual increase in the relative impairment of 17,20-lyase activity by insulin in obese populations with PCOS might limit the utility of DHEAS as a reliable marker of positive association between hyperinsulinemia and adrenal hyperandrogenism in this group of patients. The gene discussed is INS; the disease is Hyperinsulinemia.